MA30590B1 - Nouveaux analogues de peptide vasoactif intestinal - Google Patents

Nouveaux analogues de peptide vasoactif intestinal

Info

Publication number
MA30590B1
MA30590B1 MA31568A MA31568A MA30590B1 MA 30590 B1 MA30590 B1 MA 30590B1 MA 31568 A MA31568 A MA 31568A MA 31568 A MA31568 A MA 31568A MA 30590 B1 MA30590 B1 MA 30590B1
Authority
MA
Morocco
Prior art keywords
vasoactive peptide
novel analogues
intestinal vasoactive
intestinal
novel
Prior art date
Application number
MA31568A
Other languages
English (en)
Inventor
David Robert Bolin
Wajiha Khan
Hanspeter Michel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38786842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA30590(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA30590B1 publication Critical patent/MA30590B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Nouveaux analogues du peptide vasoactif intestinal Un agoniste du récepteur VPAC-2 répondant à la formule [X-(SEQ ID N° 2)-Y] pour le traitement d'affections pulmonaires obstructives, par exemple la BPCO, administré, par exemple, par inhalation.
MA31568A 2006-07-06 2009-01-13 Nouveaux analogues de peptide vasoactif intestinal MA30590B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81880506P 2006-07-06 2006-07-06

Publications (1)

Publication Number Publication Date
MA30590B1 true MA30590B1 (fr) 2009-07-01

Family

ID=38786842

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31568A MA30590B1 (fr) 2006-07-06 2009-01-13 Nouveaux analogues de peptide vasoactif intestinal

Country Status (20)

Country Link
US (1) US20080096807A1 (fr)
EP (1) EP2041168A2 (fr)
JP (1) JP2009542593A (fr)
KR (1) KR20090027239A (fr)
CN (1) CN101484468A (fr)
AR (1) AR061825A1 (fr)
AU (1) AU2007271274A1 (fr)
BR (1) BRPI0714306A2 (fr)
CA (1) CA2656757A1 (fr)
CL (1) CL2007001956A1 (fr)
CR (1) CR10518A (fr)
EC (1) ECSP099029A (fr)
IL (1) IL196122A0 (fr)
MA (1) MA30590B1 (fr)
MX (1) MX2009000013A (fr)
NO (1) NO20090027L (fr)
PE (1) PE20081000A1 (fr)
RU (1) RU2009103811A (fr)
TW (1) TW200819139A (fr)
WO (1) WO2008003612A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012012383A (es) 2010-04-30 2012-11-30 Sanwa Kagaku Kenkyusho Co Peptido para mejorar la bioestabilidad de una sustancia bioactica y sustancia bioactiva que tiene bioestabilidad mejorada.
CN102827268B (zh) * 2011-06-13 2016-08-24 中肽生化有限公司 新型血管肠肽类似物及其制备方法和用途
US8866872B2 (en) 2011-06-21 2014-10-21 Mitel Networks Corporation Conferencing and collaboration system and methods thereof
WO2014145718A2 (fr) 2013-03-15 2014-09-18 Longevity Biotech, Inc. Peptides comprenant des acides aminés non endogènes et procédés de fabrication et d'utilisation associés
US11052132B2 (en) * 2014-05-08 2021-07-06 Phasebio Pharmaceuticals, Inc. Methods and compositions for treating cystic fibrosis
ITUB20159175A1 (it) * 2015-12-23 2017-06-23 Materie Plastiche Pisane S R L Composizione polimerica antibatterica

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879371A (en) * 1971-09-17 1975-04-22 Sami I Said Isolation of vasoactive intestinal peptide
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
GB8525852D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
JPS62246595A (ja) * 1986-04-17 1987-10-27 Eisai Co Ltd 気菅支拡張作用・降圧作用ペプタイド
US4835252A (en) * 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
AU656230B2 (en) * 1991-10-11 1995-01-27 F. Hoffmann-La Roche Ag Cyclic vasoactive peptides
CN1186355C (zh) * 1996-02-09 2005-01-26 霍夫曼-拉罗奇有限公司 血管活性肠肽类似物的合成
US20050203009A1 (en) * 2004-03-12 2005-09-15 Bayer Pharmaceuticals Corporation VPAC1 selective antagonists and their pharmacological methods of use
EP1781692A2 (fr) * 2004-08-18 2007-05-09 Eli Lilly And Company Recepteur selectif vpac2 pour agonistes peptidiques
BRPI0516126A (pt) * 2004-10-08 2008-08-26 Forbes Medi Tech Res Inc produtos farmacêuticos de polipeptìdeos intestinais vasoativos

Also Published As

Publication number Publication date
BRPI0714306A2 (pt) 2014-05-20
ECSP099029A (es) 2009-02-27
CR10518A (es) 2009-01-27
IL196122A0 (en) 2011-08-01
MX2009000013A (es) 2009-01-23
PE20081000A1 (es) 2008-08-06
CN101484468A (zh) 2009-07-15
AU2007271274A1 (en) 2008-01-10
KR20090027239A (ko) 2009-03-16
EP2041168A2 (fr) 2009-04-01
JP2009542593A (ja) 2009-12-03
WO2008003612A3 (fr) 2008-02-28
CA2656757A1 (fr) 2008-01-10
AR061825A1 (es) 2008-09-24
TW200819139A (en) 2008-05-01
WO2008003612A2 (fr) 2008-01-10
NO20090027L (no) 2009-01-15
CL2007001956A1 (es) 2008-04-18
RU2009103811A (ru) 2010-08-20
US20080096807A1 (en) 2008-04-24

Similar Documents

Publication Publication Date Title
MA30590B1 (fr) Nouveaux analogues de peptide vasoactif intestinal
HRP20201215T1 (hr) Ljudska anti-il-23 antitijela, sastavi, postupci i upotrebe
EA201000157A1 (ru) Неосновные антагонисты рецептора меланин-концентрирующего гормона 1 типа и их применение
BR112012014475A2 (pt) derivados de glp-acilados.
MX355361B (es) Derivados de peptido 1 tipo glucagon (glp-1) doblemente acilados.
MX2009013138A (es) Polipeptidos, dominios variables de anticuerpo y antagonistas.
NO20081772L (no) Ikke-basiske antagonister av melaninkonsentrerende hormon-reseptor-1
RU2017105115A (ru) Пептидные ингибиторы рецептора интерлейкина-23 для перорального приема и их применение для лечения воспалительных заболеваний кишечника
EA201200876A1 (ru) Новые антагонисты рецептора ccr2 и их применение
WO2008149144A3 (fr) Polypeptides, domaines variables d'anticorps et antagonistes
MX2010001236A (es) Derivados de 5-fenil-isoxazol-3-carboxamida como moduladores del receptor de potencial transitorio v1 (trpv1).
ATE495744T1 (de) Opioide zur behandlung von chronisch-obstruktiver lungenerkrankung (copd)
TW200800979A (en) Halogenated sulfonamide derivatives
ECSP10010266A (es) Antagonistas del receptor mineralcorticoide no esteroidal derivado de 6h-dibenzo[b,e]oxepina
WO2008041133A3 (fr) Utilisation de dérivés chlorés du guanabenz pour traiter des maladies associées à l'expansion de polyglutamine
JP2025108536A (ja) 新規な分子
RU2661895C2 (ru) Соединение сложного эфира гуанидинобензойной кислоты
HUP0400222A2 (hu) PDE-4 inhibitort és H1 receptor antagonistát tartalmazó kombináció és ennek alkalmazása tüdőbetegségek kezelésére alkalmas gyógyszerkészítmény előállítására
NO20080552L (no) GLP-1 farmasoytiske sammensetninger
EA201101211A1 (ru) 5-(2-{[6-(2,2-дифтор-2-фенилэтокси)гексил]амино}-l-гидроксиэтил)-8-гидроксихинолин-2(1h)-oh и его применение для лечения легочных заболеваний
JO2937B1 (en) Tight muscles of the peptide vascular tensioner receptor
WO2007114902A3 (fr) Composés d'alkylthiobenzylpipéridine
US12605378B2 (en) Small therapeutic molecules capable of inhibiting the catalytic activity of the main protease enzyme of SARS-CoV-2
EA200400639A1 (ru) Фармацевтическая комбинация агонистов аденозиновых a-2a и бета-2-адренергических рецепторов
WO2022013809A3 (fr) Utilisation d'antagonistes de mglur5